Systematic Literature Review of the Economic Burden of Celiac Disease
ConclusionsMost of the few available economic studies of CD assess testing and diagnosis costs, especially in Europe. Methods of testing generally are considered cost effective when they combine diagnostic modalities in symptomatic patients. Most costs to a payer of managing CD derive from outpatient care. Following GFD initiation, patients lose fewer days from work and school than pretreatment.
Source: PharmacoEconomics - Category: Health Management Source Type: research
More News: Canada Health | Celiac Disease | Coeliac Disease | Databases & Libraries | Diets | Emergency Medicine | Esophagogastroduodenoscopy | Gluten | Health Management | Netherlands Health | Nutrition | Panendoscopy | Primary Care | Study